Literature DB >> 1612774

Appearance and detection of multiple copies of the mdr-1 gene in clinical samples of mammary carcinoma.

U Lönn1, S Lönn, U Nylen, B Stenkvist.   

Abstract

To examine the presence of multiple copies of the mdr-I gene in clinical tumor samples we have developed an approach where the cells are obtained by fine-needle biopsies and the number of gene copies determined by PCR. The temporal appearance of amplified mdr-I was examined in 20 breast-cancer patients with clinical stage-IV disease receiving endocrine treatment. Tumor samples were obtained every 2nd to 3rd month from the same tumor lesion. None of the initial samples from each patient contained multiple copies of mdr-I. Of 16 patients who showed increased tumor size, 4 developed multiple gene copies, showing that the event occurs without cytotoxic selection of cells with chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1612774     DOI: 10.1002/ijc.2910510503

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Biological indices in the assessment of breast cancer.

Authors:  A S Leong; A K Lee
Journal:  Clin Mol Pathol       Date:  1995-10

Review 2.  The use of reverse transcriptase-polymerase chain reaction (RT-PCR) to investigate specific gene expression in multidrug-resistant cells.

Authors:  L O'Driscoll; C Daly; M Saleh; M Clynes
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

3.  Prognostic significance of c-erb-B2 amplification in fine-needle biopsies of breast cancer patients not operated at diagnosis.

Authors:  U Lönn; S Lönn; B Nilsson; B Stenkvist
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  MRP3: a molecular target for human glioblastoma multiforme immunotherapy.

Authors:  Chien-Tsun Kuan; Kenji Wakiya; James E Herndon; Eric S Lipp; Charles N Pegram; Gregory J Riggins; Ahmed Rasheed; Scott E Szafranski; Roger E McLendon; Carol J Wikstrand; Darell D Bigner
Journal:  BMC Cancer       Date:  2010-09-01       Impact factor: 4.430

Review 5.  Molecular cytogenetics of multiple drug resistance.

Authors:  P V Schoenlein
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

6.  Detection and temporal appearance of multiple copies of c-erb-B2 genes in advanced mammary carcinoma using fine needle biopsies and the polymerase chain reaction.

Authors:  U Lönn; S Lönn; U Nylen; B Stenkvist; B Vennström
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

7.  Breast cancer: prognostic significance of c-erb-B2 and int-2 amplification compared with DNA ploidy, S-phase fraction, and conventional clinicopathological features.

Authors:  U Lönn; S Lönn; B Nilsson; B Stenkvist
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.